Category Neuropad screening test
Use of Neuropad® as a screening test shown to be highly cost-effective
Neuropad® – a simple, effective indicator for early neuropathy
Cost effectiveness of Neuropad® screening based on NHS data
Comparing Neuropad® to the 10g monofilament and biothesiometer
Advantages of early diagnosis of diabetic neuropathy
NICE publishes its Neuropad® Adoption Scoping Report
Diabetic peripheral neuropathy is a major complication in type 1 and 2 diabetes
NICE to develop Neuropad® guidance
Neuropad® a ‘great innovation’ says NHS
Neuropad® detects hidden autonomic nerve damage in Colombian patients with type 2 diabetes
